|
Volumn 395, Issue 10220, 2020, Pages 247-
|
The antimicrobial crisis: enough advocacy, more action
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
ANTIINFECTIVE AGENT;
ANTIPARASITIC AGENT;
ANTIVIRUS AGENT;
VACCINE;
ANTIBIOTIC RESISTANCE;
ANTIMICROBIAL STEWARDSHIP;
DISEASE TRANSMISSION;
DRUG INDUSTRY;
DRUG MARKETING;
EDITORIAL;
ESCHERICHIA COLI;
EVIDENCE BASED MEDICINE;
FUNDING;
HEALTH CARE ACCESS;
INFECTION CONTROL;
KLEBSIELLA PNEUMONIAE;
PATIENT ADVOCACY;
PRIORITY JOURNAL;
WORLD HEALTH ORGANIZATION;
ECONOMICS;
GLOBAL HEALTH;
HUMAN;
ANTI-BACTERIAL AGENTS;
ANTIMICROBIAL STEWARDSHIP;
DRUG INDUSTRY;
DRUG RESISTANCE, BACTERIAL;
GLOBAL HEALTH;
HUMANS;
|
EID: 85078347975
PISSN: 01406736
EISSN: 1474547X
Source Type: Journal
DOI: 10.1016/S0140-6736(20)30119-7 Document Type: Editorial |
Times cited : (18)
|
References (0)
|